Navigation Links
Baxter Reports Solid First Quarter Financial Results and Raises Full-Year Outlook
Date:4/17/2008

sruptive technologies; reimbursement policies of government agencies and private payers; the availability of acceptable raw materials and component supply; the ability to enforce company patents; patents of third parties preventing or restricting the company's manufacture, sale or use of affected products or technology; foreign currency fluctuations and other risks identified in the company's most recent filing on Form 10-K and other Securities and Exchange Commission filings, all of which are available on the company's website. The company does not undertake to update its forward-looking statements. Financial schedules are attached to this release and available on the company's website.

BAXTER INTERNATIONAL INC.

Consolidated Statements of Income

Three Months Ended March 31, 2008 and 2007

(unaudited)

(in millions, except per share and percentage data)

Three Months Ended

March 31,

--------------------

2008 2007 Change

------- ------- --------

NET SALES $2,877 $2,675 8%

COST OF GOODS SOLD 1,497 (1) 1,409 6%

------------------------------------------------------------------------

GROSS PROFIT 1,380 1,266 9%

------------------------------------------------------------------------

% of Sales 48.0% 47.3% 0.7 pts

MARKETING AND ADMINISTRATIVE EXPENSES 640 583 10%

% of Sales 22.2% 21.8% 0.4 pts

RESE
'/>"/>

SOURCE Baxter International Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19

Related biology technology :

1. Baxter to Launch GARDian(TM), a Groundbreaking Initiative That Helps Provide Continued Access to GAMMAGARD for Current Patients
2. Baxter and Halozyme Announce Collaboration for Development of Subcutaneous GAMMAGARD LIQUID(TM) Administration Using Enhanze(TM) Technology
3. Baxter Named to Dow Jones Sustainability Index for Ninth Consecutive Year
4. Baxter and Novation Sign Multi-Year Contract Extension Valued at Over $200 Million for Medication Delivery Products
5. Baxter Adds Recombinant Protein to Specialty Therapeutics Portfolio
6. Baxter Kidney Patient Education Program Celebrates Tenth Anniversary
7. Baxter Receives 510(k) Clearance From FDA For V-Link With VitalShield, New Antimicrobial Intravascular Technology
8. Baxter Announces FDA Approval of GELFOAM(R) Plus Hemostasis Kit
9. Baxter International Fourth Quarter 2007 Financial Results Conference Call
10. Baxter Issues Urgent Nationwide Voluntary Recall of Heparin 1,000 Units/mL 10 and 30mL Multi-Dose Vials
11. Baxters Costa Rica Facility Recognized With Shingo Prize for Excellence in Manufacturing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2009)... - 45 Patients Enrolled ... Cells to Restore Cardiac Function ,, ... company specialising,in cell-based therapies for the treatment of ... months ahead of schedule,enrolment in the first stage ... a,unique stem cell therapy for heart failure. Forty-five ...
(Date:12/14/2009)... OAKS, Calif., Dec. 14 Array BioPharma ... AMGN ) today announced that they entered ... to Array,s small-molecule glucokinase activator program, including ARRY-403, ... trial in patients with Type 2 diabetes. ... Array will receive an upfront payment of $60 ...
(Date:12/14/2009)... JUPITER, Fla., Dec. 14 Dyadic International, ... it has extended its collaboration with The Scripps ... with Scripps to re-annotate the genome of Dyadic,s ... agreement is a continuation of the successful relationship ... 2006 when Dyadic engaged Scripps to annotate the ...
(Date:12/14/2009)... 14 The third edition of ... , published by the Infusion Nurses Society ... anthracycline extravasation.(1) Anthracyclines are a group of ... that have been used in the treatment of ... ,, According to the INS publication: ...
Breaking Biology Technology:Cardio3 BioSciences Completes Patient Enrolment in First Stage of Pivotal Trial of C-Cure(R) in Heart Failure 2Cardio3 BioSciences Completes Patient Enrolment in First Stage of Pivotal Trial of C-Cure(R) in Heart Failure 3Array BioPharma and Amgen Partner in Type 2 Diabetes 2Array BioPharma and Amgen Partner in Type 2 Diabetes 3Array BioPharma and Amgen Partner in Type 2 Diabetes 4Array BioPharma and Amgen Partner in Type 2 Diabetes 5Array BioPharma and Amgen Partner in Type 2 Diabetes 6Array BioPharma and Amgen Partner in Type 2 Diabetes 7Dyadic International Extends Collaboration With The Scripps Research Institute 2Dyadic International Extends Collaboration With The Scripps Research Institute 3Dyadic International Extends Collaboration With The Scripps Research Institute 4Dyadic International Extends Collaboration With The Scripps Research Institute 5Infusion Nurses Society References Totect(R) (Dexrazoxane For Injection) as the Only Antidote for the Treatment of Anthracycline Extravasation 2Infusion Nurses Society References Totect(R) (Dexrazoxane For Injection) as the Only Antidote for the Treatment of Anthracycline Extravasation 3Infusion Nurses Society References Totect(R) (Dexrazoxane For Injection) as the Only Antidote for the Treatment of Anthracycline Extravasation 4Infusion Nurses Society References Totect(R) (Dexrazoxane For Injection) as the Only Antidote for the Treatment of Anthracycline Extravasation 5
... ... ... pharmaceuticals company, today announced,that it had successfully closed a third ... developing its unique,CriticalMix delivery technology and matching pipeline of candidate ...
... developed a new type of small-scale electric power generator ... and releasing of zinc oxide wires encapsulated in a ... , The new "flexible charge pump" generator is the ... by using the piezoelectric properties of zinc oxide structures ...
... Hoex and research group Plasma & Materials Processing (PMP) ... been awarded the Leverhulme Technology Transfer Award 2008. They ... 63,000 for the research group) for their successful transfer ... year Hoex,s Ph.D. research was rewarded with the SolarWorld ...
Other Biology Technology:Critical Pharmaceuticals Raise GBP650K 2Critical Pharmaceuticals Raise GBP650K 3New small-scale generator produces alternating current by stretching zinc oxide wires 2New small-scale generator produces alternating current by stretching zinc oxide wires 3TU/e awarded for knowledge transfer to solar energy industry 2
(Date:12/15/2009)... Economics, environmental impacts, social dynamics, and production ... overall success of an agroecosystem. Positive or negative, ... individuals and social groups to continuously adapt farming ... , Experiential learning theory suggests that knowledge is ... Such lessons are especially valuable for environmental and ...
(Date:12/15/2009)... is available in German ., Despite ... across the globe, cultures vary as to how space ... not use egocentric terms such as ,left, right, front, ... notions like ,north, south, east, west, at all times ... bowl" or "There is an snake by your Northern ...
(Date:12/15/2009)... toll on society. It is estimated that 100 to ... waters and it,s likely that rip currents account for more ... between rip current research and public understanding. Rip currents ... importantly, most people do not know how to even identify, ... of the Rip Current Symposium is to identify advancements in ...
Breaking Biology News(10 mins):Experiential learning teaches change and adaptation 2More than a jump to the left 2The Nations Mayors Commend House Passage of Health Reform Bill 60932 1The Nations Mayors Commend House Passage of Health Reform Bill 60932 2Findings show nanomedicine promising for treating spinal cord injuries 10653 1Findings show nanomedicine promising for treating spinal cord injuries 10653 2Findings show nanomedicine promising for treating spinal cord injuries 10653 3College Invites Public to Explore Career Options in Health Care 60926 1College Invites Public to Explore Career Options in Health Care 60926 2
... scientists have struggled to understand the decline and slow ... prized game and food fish native to New England ... salmon in the U.S. and Canada, but specific causes ... tags and associated technology may provide some answers. ...
... Platelets those tiny, unassuming cells that cause blood to ... play an important early role in promoting cerebral malaria, an ... many as half a billion people in tropical and subtropical ... the parasite responsible for it, Plasmodium, among the most studied ...
... researchers have developed a new gene silencing technology that ... to the development of certain diseases. This technology could ... plays a role. The groundbreaking research was led by ... of Structural and Chemical Biology at Mount Sinai School ...
Other Biology News:Signals from the Atlantic salmon highway 2Signals from the Atlantic salmon highway 3Signals from the Atlantic salmon highway 4Johns Hopkins scientists discover what drives the development of a fatal form of malaria 2
...
...
Healthy animals 10-32 weeks of age, mixed gender and breed; collected on wet ice following USDA guidelines, using Alsevers solution at 1:2 dilution...
... The Zero Blunt TOPO ... the fastest and easiest ... than or equal to95%) ... products amplified with proofreading ...
Biology Products: